AL
TPST icon

AJO LP’s Tempest Therapeutics TPST Stock Holding History

AJO LP’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-21
Closed -$86K – 678
2017
Q4 		$86K Buy
+21
New +$88.1K ﹤0.01% 599

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

AJO LP's TPST Position: Q1 2018 in Review

AJO LP sold out of Tempest Therapeutics (TPST) in Q1 2018, closing a stake of 21 shares — an estimated $86K sold.

AJO LP first reported a position in TPST in Q4 2017 and held it in 1 quarter. The position peaked at $86K in Q4 2017. 41 funds tracked by Wall St. Rank hold TPST as of Q1 2018.

  • AJO LP reported no remaining Tempest Therapeutics position as of Q1 2018 after selling out during the quarter.
  • AJO LP sold 21 Tempest Therapeutics shares in Q1 2018, an estimated $86K.
  • AJO LP first reported a position in Tempest Therapeutics in Q4 2017 and held it in 1 quarter.
  • AJO LP's Tempest Therapeutics position peaked at $86K in Q4 2017.
  • 41 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q1 2018.

Based on AJO LP's 13F filing for Q1 2018, filed 14 May 2018.